NCT04803435

Brief Summary

Acute gastroenterocolitis (GECA) in healthy adults is a frequent cause of looking for medical care in emergency care units and most cases are aimed at etiology viral infection or food toxin, being generally self-limited with good prognosis and only need for treatment with behavioral measures and use of medications for relief symptomatic. Anamnesis is the main resource for the diagnosis and stratification of GECA severity and is infrequent alterations of physical examination and complementary examinations without association with symptoms of alert. Telemedicine has become a resource that allows easier and faster access to medical evaluation, with low cost and rational use of resources. Virtual emergency care is part of Hospital Israelita Albert Einstein (HIAE) institutional routine and there is a large number of consultations whose final diagnosis was GECA. It is not known whether the accuracy of diagnosis of GECA by telemedicine is not inferior to the diagnosis by face-to-face evaluation, considered the Golden pattern. The aim of the study is compare the diagnostic accuracy of GECA by telemedicine with that of face-to-face care. It is a prospective randomized study with a population of adult patients who sought in person the screening of the Morumbi Emergency Care Unit of HIAE with symptoms suggestive of GECA (diarrhea with or without other symptoms of the digestive tract and infectious). Patients whose screening will be excluded of nursing directed for immediate evaluation in the emergency room and patients with dysfunctions organisms or immunosuppression. Patients who accept and sign the informed consent form will be randomized into 2 groups: A) immediate face-to-face evaluation; B) evaluation initially by telemedicine and sequentially at face-to-face evaluation. In both cases, the ICD diagnostics will be compiled and grouped according to clinical significance and will be the primary outcome of the study. Service time, exams requested, guidelines, prescription and destination will also be analyzed. Patients and doctors who undergoing group B assessment will be blinded to the telemedicine assessment data.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 11, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 17, 2021

Completed
11 months until next milestone

Study Start

First participant enrolled

February 20, 2022

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

February 11, 2022

Status Verified

March 1, 2021

Enrollment Period

9 months

First QC Date

March 11, 2021

Last Update Submit

February 10, 2022

Conditions

Keywords

DiarrheaTelemedicineEmergency Medical Services

Outcome Measures

Primary Outcomes (1)

  • Accuracy of telemedicine diagnosis of adult patients with symptoms compatible with acute gastrointestinal infection

    The patient will be evaluated by telemedicine and / or face-to-face consultation and at the end will receive the diagnosis, which will be assigned the ICD code. At the end, these ICDs will be grouped by the same clinical significance and will be compared between the two consultation methods (telemedicine versus face-to-face consultation).

    through study completion, an average of 1 year

Secondary Outcomes (6)

  • Time of medical care

    through study completion, an average of 1 year

  • Rate of indication for complementary exams

    through study completion, an average of 1 year

  • Types of requested exams

    through study completion, an average of 1 year

  • Guidelines follow-up

    through study completion, an average of 1 year

  • Medical prescription

    through study completion, an average of 1 year

  • +1 more secondary outcomes

Study Arms (2)

Adult patients with acute gastrointestinal infection - telemedicine before face-to-face evaluation

ACTIVE COMPARATOR

Adult patients who sought in person the screening of the Morumbi Emergency Care Unit of HIAE with symptoms suggestive of GECA (diarrhea with or without other symptoms of the digestive tract and infectious) who have undergone telemedicine consultation before face-to-face evaluation

Other: Telemedicine ConsultationOther: Face-to-face Consultation

Adult patients with acute gastrointestinal infection - only face-to-face evaluation

ACTIVE COMPARATOR

Adult patients who sought in person the screening of the Morumbi Emergency Care Unit of HIAE with symptoms suggestive of GECA (diarrhea with or without other symptoms of the digestive tract and infectious) who have only face-to-face evaluation

Other: Face-to-face Consultation

Interventions

Brief telemedicine consultation, blindedto subsequent face-to-face evaluation.

Adult patients with acute gastrointestinal infection - telemedicine before face-to-face evaluation

Direct face-to-face evaluation (without telemedicine consultation before).

Adult patients with acute gastrointestinal infection - only face-to-face evaluationAdult patients with acute gastrointestinal infection - telemedicine before face-to-face evaluation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age\> 18 years
  • Symptoms present less than 7 days.
  • Without the use of antibiotics in last 30 days prior to the onset of symptoms.
  • No trips abroad in the last 15 days prior to the onset of symptoms.
  • Presence of more than three episodes of watery diarrhea in the last 24 hours with or without symptoms related to the infection (fever 38oC, chills, sweating, myalgia, vomiting) that motivated / were looking for the Emergency Care Unit
  • Signature of informed consent form

You may not qualify if:

  • Return to the Emergency Care Unit due to maintenance or aggravation of the complaint
  • Age\> 65 years
  • Diagnosis of chronic gastrointestinal diseases, gastritis with or without gastroesophageal reflux disease, previous diverticulitis, previous abdominal surgery, chronic colitis, inflammatory bowel diseases, food intolerances (gluten, lactose)
  • Previous diagnosis of congestive heart failure, HIV / AIDS, active cancer, type I diabetes mellitus, use of any immunosuppressant
  • Diarrhea chronic
  • Patient with emergency room criteria by the nursing evaluation of the triage.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diarrhea

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Eduardo HS Cordioli, MD

    Telemedicine Department, Hospital Israelita Albert Einstein, Sao Paulo, Brazil

    STUDY DIRECTOR

Central Study Contacts

Tarso AD Accorsi, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 11, 2021

First Posted

March 17, 2021

Study Start

February 20, 2022

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

February 11, 2022

Record last verified: 2021-03